CD38 Pretargeted Radioimmunotherapy for Myeloma

Andrew G Myers

Synthesis and Study of Natural and Non-natural Antiproliferative Agents

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Martha Lassiter

Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Multiple myeloma and immunoproliferative diseases

Robert M Williams

Multiple Myeloma and Cancer Therapies via Largazole Analogs

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Irene M. Ghobrial

The role of miRNA15a and 16-1 in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Lindsay Morton

Childhood cancer survivor study (CCSS)

Sarcoma Thyroid Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Melanoma of skin Lip, oral cavity Leukaemia Larynx Kidney, renal pelvis and ureter Hodgkin lymphoma Breast Brain, nervous system

Radiation Oncology Pediatric oncology or childhood cancer

Ruben D Carrasco

Validating the eCyPA/CD147 signaling complex for myeloma therapy

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Ratneshwar Lal

Amyloid ion channels to design therapeutics for neurodegenerative diseases

Multiple myeloma and immunoproliferative diseases

Pathology

David L Woodland

Immune Evolution in Cancer

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Jens G Lohr

Determining the mutational landscape of circulating multiple myeloma cells

Multiple myeloma and immunoproliferative diseases

Pathology